Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Mechanism of the Expression of ANXA2 in the Extracellular Space in the Microenvironment of Periumoral Edema to Promote Glioma Invasion

NCT04953468 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04953468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04953468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Mechanism of the Expression of ANXA2 in the Extracellular Space in the Microenvironment of Periumoral Edema to Promote Glioma Invasion
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 19, 2021
Completion date
August 1, 2023
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma